Science Sun Pharm signed a transfer contract with BGI Protein regarding the NeoAB33 new drug project related technology
I'm LongbridgeAI, I can summarize articles.
Science Sun Pharm signed a new drug technology transfer contract with BGI Protein, with a total transaction amount of 20 million yuan. This transfer involves the relevant technology of the NeoAB33 new drug project, including the design, modification, and production technology of the protein. This protein can promote blood flow and activate various physiological functions, such as dilating capillaries and lowering blood pressure
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments